John Peter Gutfreund - Net Worth and Insider Trading
John Peter Gutfreund Net Worth
The estimated net worth of John Peter Gutfreund is at least $9,131 dollars as of 2024-11-29. John Peter Gutfreund is the Director of OncoCyte Corp and owns about 3,750 shares of OncoCyte Corp (OCX) stock worth over $9,131. Details can be seen in John Peter Gutfreund's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John Peter Gutfreund has not made any transactions after 2022-12-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of John Peter Gutfreund
John Peter Gutfreund Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, John Peter Gutfreund owns 1 companies in total, including OncoCyte Corp (OCX) .
Click here to see the complete history of John Peter Gutfreund’s form 4 insider trades.
Insider Ownership Summary of John Peter Gutfreund
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| OCX | OncoCyte Corp | 2023-06-30 | other: Former Director |
John Peter Gutfreund Latest Holdings Summary
John Peter Gutfreund currently owns a total of 1 stock. John Peter Gutfreund owns 3,750 shares of OncoCyte Corp (OCX) as of December 23, 2022, with a value of $9,131.
Latest Holdings of John Peter Gutfreund
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| OCX | OncoCyte Corp | 2022-12-23 | 3,750 | 2.44 | 9,131 |
Holding Weightings of John Peter Gutfreund
John Peter Gutfreund Form 4 Trading Tracker
According to the SEC Form 4 filings, John Peter Gutfreund has made a total of 2 transactions in OncoCyte Corp (OCX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in OncoCyte Corp is the acquisition of 3,750 shares on December 23, 2022, which cost John Peter Gutfreund around $24,750.
Insider Trading History of John Peter Gutfreund
- 1
John Peter Gutfreund Trading Performance
GuruFocus tracks the stock performance after each of John Peter Gutfreund's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John Peter Gutfreund is -48.44%. GuruFocus also compares John Peter Gutfreund's trading performance to market benchmark return within the same time period. The performance of stocks bought by John Peter Gutfreund within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how John Peter Gutfreund's insider trading performs compared to the benchmark.
Performance of John Peter Gutfreund
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 5.82 | | | | | |
| Relative Return to S&P 500(%) | 8.15 | | | | | |
John Peter Gutfreund Ownership Network
John Peter Gutfreund Owned Company Details
What does OncoCyte Corp do?
Who are the key executives at OncoCyte Corp?
John Peter Gutfreund is the other: Former Director of OncoCyte Corp. Other key executives at OncoCyte Corp include 10 percent owner Broadwood Partners Lp , Interim CEO Josh Riggs , and 10 percent owner Pura Vida Investments, Llc .
OncoCyte Corp (OCX) Insider Trades Summary
Over the past 18 months, John Peter Gutfreund made no insider transaction in OncoCyte Corp (OCX). Other recent insider transactions involving OncoCyte Corp (OCX) include a net purchase of 3,735,339 shares made by Broadwood Partners Lp , a net purchase of 33,898 shares made by Andrew Arno , and a net purchase of 33,670 shares made by .
In summary, during the past 3 months, insiders sold 0 shares of OncoCyte Corp (OCX) in total and bought 1,349,009 shares, with a net purchase of 1,349,009 shares. During the past 18 months, 0 shares of OncoCyte Corp (OCX) were sold and 3,807,797 shares were bought by its insiders, resulting in a net purchase of 3,807,797 shares.
OncoCyte Corp (OCX)'s detailed insider trading history can be found in Insider Trading Tracker table.
OncoCyte Corp Insider Transactions
John Peter Gutfreund Mailing Address
Above is the net worth, insider trading, and ownership report for John Peter Gutfreund. You might contact John Peter Gutfreund via mailing address: 767 5th Avenue, 44th Floor, New York Ny 10153.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
